I have no clue what the price equivalence would be for MS, but the TGTX CEO has said it doesn't matter if they have to drastically undercut other MS drugs, plenty of margin to spare and a big market. fwiw.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.